Financing channel feed – Endpoints News

Financing channel feed

A small buyout deal gives a penny-stock biotech a boost and a second chance

5 years ago

RemeGen readies $514M IPO as HKEX adds jewel to the crown

5 years ago

Arena's Amit Munshi spins out his neuro sub into a biotech startup, with $56M for the baptism

5 years ago

Biogen chair Stelios Papadopoulos takes his investing experience to the SPAC party, raising $100M for a blank check deal

5 years ago

Foghorn hits Nasdaq in $120M debut as the biotech IPO boom shows no sign of slowing

5 years ago

Bain execs Adam Koppel and Jeffrey Schwartz line up $125M for their first blank check deal as Wall Street continues to embrace biotech

5 years ago

Chinese investors wager $105M on an IPO-bound biotech looking to push RNAi as mainstream cancer therapy

5 years ago

Can B cells break the boundaries of cell therapy? Longwood startup has $52M to prove a new engineering tech

5 years ago

Azura Ophthalmics gets a $20M boost for its R&D work on eye diseases

5 years ago

Bo Cumbo jumps from the top commercial post at Sarepta to the helm of a gene therapy startup with some influential backers, big plans and $107M

5 years ago

Peter Kolchinsky and Raj Shah's RA Capital has $461M more to play with, after 'rapid' investment in the last 15 months

5 years ago

Promising better linker tech to ADC field, Araris has 'very, very ambitious' plans for the clinic

5 years ago

Looking to repurpose an old drug to treat irregular heartbeats, InCarda raises $30M in first Series C close

5 years ago

UC San Diego spinout awarded up to $15M for nanosponge designed to soak up sepsis-causing toxins

5 years ago

SparingVision raises $52M to kick off long journey for a next-gen gene therapy that goes much, much broader than Luxturna

5 years ago

Months after striking a deal with Sanofi, AbSci nails its largest fundraise yet to support its protein printing tech

5 years ago

MD Anderson establishes new $50M+ biotech fund to choose the next promising cancer therapies

5 years ago

Bringing their genetically modified gamma delta T cells to Nasdaq, IN8bio files for $86M IPO

5 years ago

CAR-plus: Irish biotech recruits Kite alum Chris Nowers to prep dual-targeting NK cell therapy for the clinic

5 years ago

Four biotechs and a Matthew Roden-led SPAC price IPOs, raising a combined $528M

5 years ago

Codiak lands on Wall Street in second shot at IPO, raises $83M

5 years ago

Luca Santarelli’s PhIII is good to go, he has a new app to stop Covid-19 from infecting the data and $110M to pave the way

5 years ago

Polyphor bags second grant in two years for a new class of antibiotics to fight drug-resistant bacteria

5 years ago

Novartis bet $6B on the idea — now Versant, venBio have $45M to birth a platform play for radiopharmaceuticals

5 years ago

First page Previous page 88 89 909192 93 94 Next page Last page